S. Luzi, P.D. Morrison, J. Powell, M. Di Forti i inni. What is the mechanism whereby cannabis use increases risk of psychosis?. „Neurotoxicity Research”. 14 (2–3), s. 105–112, 2008. DOI: 10.1007/BF03033802. PMID: 19073418. (ang.).
C. Henquet, M. Di Forti, P. Morrison, R. Kuepper i inni. Gene-Environment Interplay Between Cannabis and Psychosis. „Schizophrenia Bulletin”. 34 (6), s. 1111–1121, 2008. DOI: 10.1093/schbul/sbn108. PMID: 18723841. (ang.).
Matthew Large, Swapnil Sharma, Michael T. Compton, Tim Slade i inni. Cannabis Use and Earlier Onset of Psychosis. „Archives of General Psychiatry”. 68 (6), s. 555, 2011-06-06. DOI: 10.1001/archgenpsychiatry.2011.5.
B. Chadwick, M.L. Miller, Y.L. Hurd. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. „Frontiers in Psychiatry”. 4, s. 129, 2013. DOI: 10.3389/fpsyt.2013.00129. PMID: 24133461. PMCID: PMC3796318.
Rajiv Radhakrishnan, Samuel T. Wilkinson, Deepak Cyril D’Souza. Gone to Pot – A Review of the Association between Cannabis and Psychosis. „Frontiers in Psychiatry”. 5, 2014-05-22. DOI: 10.3389/fpsyt.2014.00054.
D. M. Semple. Book Review: Cannabis as a risk factor for psychosis: systematic review. „Journal of Psychopharmacology”. 19 (2), s. 187–194, 2005-06-01. DOI: 10.1177/0269881105049040.
W. Hall, L. Degenhardt. Cannabis use and psychosis: A review of clinical and epidemiological evidence. „The Australian and New Zealand journal of psychiatry”. 34 (1), s. 26–34, 2000. DOI: 10.1046/j.1440-1614.2000.00685.x. PMID: 11185941. (ang.).
L. Arseneault, M. Cannon, J. Witton, R. M. Murray. Causal association between cannabis and psychosis: Examination of the evidence. „The British journal of psychiatry : the journal of mental science”. 184 (2), s. 110–117, 2004. DOI: 10.1192/bjp.184.2.110. PMID: 14754822. (ang.).
Filip Smit, Linda Bolier, Pim Cuijpers. Cannabis use and the risk of later schizophrenia: a review. „Addiction”. 99 (4). s. 425–430. DOI: 10.1111/j.1360-0443.2004.00683.x.
D.C. d’Souza, R.A. Sewell, M. Ranganathan. Cannabis and psychosis/schizophrenia: Human studies. „European Archives of Psychiatry and Clinical Neuroscience”. 259 (7), s. 413–431, 2009. DOI: 10.1007/s00406-009-0024-2. PMID: 19609589. (ang.).
S.L. Matheson, A.M. Shepherd, K.R. Laurens, V.J. Carr. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. „Schizophrenia Research”. 133 (1–3), s. 133–142, 2011. DOI: 10.1016/j.schres.2011.09.020. PMID: 21999904. (ang.).
dx.doi.org
Theresa HM MooreT.H.M.MScTheresa HM MooreT.H.M. i inni, Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review., „The Lancet”, 370 (9584), 2007, s. 319–28, DOI: 10.1016/S0140-6736(07)61162-3, PMID: 17662880.
LouisaL.DegenhardtLouisaL. i inni, The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study., „PloS one”, 8 (10), 2013, e76635, DOI: 10.1371/journal.pone.0076635, PMID: 24204649, PMCID: PMC3811989.
S. Luzi, P.D. Morrison, J. Powell, M. Di Forti i inni. What is the mechanism whereby cannabis use increases risk of psychosis?. „Neurotoxicity Research”. 14 (2–3), s. 105–112, 2008. DOI: 10.1007/BF03033802. PMID: 19073418. (ang.).
C. Henquet, M. Di Forti, P. Morrison, R. Kuepper i inni. Gene-Environment Interplay Between Cannabis and Psychosis. „Schizophrenia Bulletin”. 34 (6), s. 1111–1121, 2008. DOI: 10.1093/schbul/sbn108. PMID: 18723841. (ang.).
B. Chadwick, M.L. Miller, Y.L. Hurd. Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness. „Frontiers in Psychiatry”. 4, s. 129, 2013. DOI: 10.3389/fpsyt.2013.00129. PMID: 24133461. PMCID: PMC3796318.
W. Hall, L. Degenhardt. Cannabis use and psychosis: A review of clinical and epidemiological evidence. „The Australian and New Zealand journal of psychiatry”. 34 (1), s. 26–34, 2000. DOI: 10.1046/j.1440-1614.2000.00685.x. PMID: 11185941. (ang.).
L. Arseneault, M. Cannon, J. Witton, R. M. Murray. Causal association between cannabis and psychosis: Examination of the evidence. „The British journal of psychiatry : the journal of mental science”. 184 (2), s. 110–117, 2004. DOI: 10.1192/bjp.184.2.110. PMID: 14754822. (ang.).
M. Weiser, S. Noy. Interpreting the association between cannabis use and increased risk for schizophrenia. „Dialogues in clinical neuroscience”. 7 (1), s. 81–85, 2005. PMID: 16060598. (ang.).
Theresa HM MooreT.H.M.MScTheresa HM MooreT.H.M. i inni, Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review., „The Lancet”, 370 (9584), 2007, s. 319–28, DOI: 10.1016/S0140-6736(07)61162-3, PMID: 17662880.
D.C. d’Souza, R.A. Sewell, M. Ranganathan. Cannabis and psychosis/schizophrenia: Human studies. „European Archives of Psychiatry and Clinical Neuroscience”. 259 (7), s. 413–431, 2009. DOI: 10.1007/s00406-009-0024-2. PMID: 19609589. (ang.).
LouisaL.DegenhardtLouisaL. i inni, The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study., „PloS one”, 8 (10), 2013, e76635, DOI: 10.1371/journal.pone.0076635, PMID: 24204649, PMCID: PMC3811989.
S.L. Matheson, A.M. Shepherd, K.R. Laurens, V.J. Carr. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. „Schizophrenia Research”. 133 (1–3), s. 133–142, 2011. DOI: 10.1016/j.schres.2011.09.020. PMID: 21999904. (ang.).